CIK: 0001773195
申报总市值
US$19.4亿
申报季度: 2026-03-31 · 持股只数: 105
Affinity Asset Advisors, LLC在最新一期 13F 报告中披露了 105 项持股，申报期为 2026-03-31，总持股市值约为 US$19.4亿，季度换手率为 77.9%。
Affinity Asset Advisors, LLC 目前披露的持仓，Herfindahl 集中度指数为 0.026——换算下来相当于约 38 个等权重仓位，明显低于其实际披露的 105 只持仓。这一差距显示该机构的策略偏向集中在少数高信心仓位，而非广泛分散。
整体仓位大小差异较大（变异系数为 1.30），除少数重仓仓位外，还有许多规模较小的持仓。
最新申报季度中，并未观察到明显偏向加仓既有大仓位或大举建立新仓位的倾向。
目前行业板块分类约覆盖此投资组合披露价值的 23%；其余部分（例如未匹配板块的标的、期权或其他证券类型）尚未纳入板块分类范围。
加仓 ERAS
+37.2% US$7205.5万
减仓 WVE
-48.1% -US$3573.7万
加仓 260
+133.1% US$4058.8万
加仓 ROIV
+64.7% US$4067.0万
加仓 XENE
+34.0% US$4137.6万
减仓 ABVX
-19.8% -US$2300.5万
仅显示前 103 大持股（共 105 只）
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 6.72% | +6.72% | NEW | |
| 2 | APGE | Apogee Therapeutics INC | 股票-其他 | 5.59% | +0.28% | +4.05% | |
| 3 | XENE | Xenon Pharmaceuticals INC | 股票-其他 | 5.03% | +1.84% | +34.00% | |
| 4 | ERAS | Erasca INC | 股票-其他 | 4.47% | +3.64% | +37.18% | |
| 5 | INSM | Insmed INC | 股票-医疗保健 | 4.05% | — | +6.67% | |
| 6 | ROIV | Roivant Sciences Ltd. | 股票-医疗保健 | 4.01% | +1.91% | +64.71% | |
| 7 | SYRE | Spyre Therapeutics INC | 股票-其他 | 3.33% | +0.66% | -10.71% | |
| 8 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 2.87% | +2.01% | +133.12% | |
| 9 | PRAX | Praxis Precision Medicines I | 股票-其他 | 2.83% | — | -8.11% | |
| 10 | ANAB | Anaptysbio INC | 股票-其他 | 2.69% | +1.46% | +111.38% | |
| 11 | ALKS | Alkermes plc | 股票-医疗保健 | 2.47% | +0.88% | +35.00% | |
| 12 | CYTK | Cytokinetics INC | 股票-医疗保健 | 2.38% | — | -12.44% | |
| 13 | ABVX | Abivax Sa-adr | 股票-其他 | 2.33% | -1.55% | -19.80% | |
| 14 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 2.18% | — | — | |
| 15 | ACLXGBX | Arcellx INC | 股票-其他 | 2.15% | +0.20% | -30.73% | |
| 16 | MRNA | Moderna INC | 股票-医疗保健 | 2.10% | +2.10% | NEW | |
| 17 | DNTH | Dianthus Therapeutics INC | 股票-其他 | 1.73% | +1.46% | +247.83% | |
| 18 | NUVL | Nuvalent Inc-a | 股票-其他 | 1.59% | — | -7.02% | |
| 19 | 430 | Terns Pharmaceuticals INC | 股票-其他 | 1.53% | +0.26% | +2.30% | |
| 20 | LXEO | Lexeo Therapeutics INC | 股票-其他 | 1.50% | — | +57.82% | |
| 21 | COGT | Cogent Biosciences INC | 股票-其他 | 1.49% | +0.78% | +114.29% | |
| 22 | MDGL | Madrigal Pharmaceuticals INC | 股票-医疗保健 | 1.49% | +0.46% | +76.67% | |
| 23 | STRO | Sutro Biopharma INC | 股票-其他 | 1.38% | +0.89% | +42.91% | |
| 24 | FBRX | Forte Biosciences INC | 股票-其他 | 1.35% | — | — | |
| 25 | ORKA | Oruka Therapeutics INC | 股票-其他 | 1.27% | — | -37.72% | |
| 26 | TRVI | Trevi Therapeutics INC | 股票-其他 | 1.23% | — | -6.98% | |
| 27 | OVID | Ovid Therapeutics INC | 股票-其他 | 1.22% | +0.56% | +48.76% | |
| 28 | ELVN | Enliven Therapeutics INC | 股票-其他 | 1.19% | +1.19% | NEW | |
| 29 | ASND | Ascendis Pharma A/S | 股票-其他 | 1.12% | +0.76% | +216.67% | |
| 30 | MLYS | Mineralys Therapeutics INC | 股票-其他 | 1.05% | — | +2.74% | |
| 31 | AVTX | Avalo Therapeutics INC | 股票-其他 | 1.03% | — | +27.57% | |
| 32 | RVMD | Revolution Medicines INC | 股票-医疗保健 | 1.00% | +0.55% | +100.00% | |
| 33 | BMY | Bristol-myers Squibb Co | 股票-医疗保健 | 0.94% | +0.94% | NEW | |
| 34 | PTGX | Protagonist Therapeutics INC | 股票-其他 | 0.94% | — | — | |
| 35 | CLDX | Celldex Therapeutics INC | 股票-其他 | 0.82% | — | +42.86% | |
| 36 | ✓ | Zura Bio LTD | 股票-其他 | 0.79% | — | +41.39% | |
| 37 | NRIX | Nurix Therapeutics INC | 股票-其他 | 0.77% | — | — | |
| 38 | SVRA | Savara INC | 股票-其他 | 0.71% | — | -10.19% | |
| 39 | OMER 9.5 06-15-29 | Omeros CORP | 股票-其他 | 0.68% | — | — | |
| 40 | CATX | Perspective Therapeutics INC | 股票-其他 | 0.68% | +0.63% | +954.86% | |
| 41 | ✓ | Helix Acquisition CORP Iii | 股票-其他 | 0.66% | +0.66% | NEW | |
| 42 | ARWR | Arrowhead Pharmaceuticals In | 股票-医疗保健 | 0.65% | +0.39% | +185.71% | |
| 43 | DMRA | Damora Therapeutics INC | 股票-其他 | 0.60% | +0.60% | NEW | |
| 44 | EPRX | Eupraxia Pharmaceuticals INC | 股票-其他 | 0.59% | +0.46% | +429.67% | |
| 45 | ANRO | Alto Neuroscience INC | 股票-其他 | 0.58% | +0.58% | NEW | |
| 46 | BBIO | Bridgebio Pharma INC | 股票-医疗保健 | 0.58% | -0.81% | -53.13% | |
| 47 | CGEM | Cullinan Therapeutics INC | 股票-其他 | 0.57% | -0.57% | -59.56% | |
| 48 | BLTE | Belite Bio INC - Adr | 股票-其他 | 0.54% | +0.36% | +225.00% | |
| 49 | WVE | Wave Life Sciences Ltd. | 股票-其他 | 0.52% | -2.10% | -48.08% | |
| 50 | VERA | Vera Therapeutics INC | 股票-其他 | 0.52% | — | — |
Q3 2026表现
+21.4%
近4个季度表现
+94.4%
基于可获取价格的持仓（占申报价值的77%）计算
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 105 | US$19.4亿 | 78 | |
| 2025-12-31 | 95 | US$17.6亿 | 96 | |
| 2025-09-30 | 96 | US$11.5亿 | 100 | |
| 2025-06-30 | 91 | US$7.3亿 | 0 | |
| 2025-03-31 | 98 | US$10.5亿 | 100 | |
| 2024-12-31 | 85 | US$7.5亿 | 0 | |
| 2024-09-30 | 86 | US$7.3亿 | 0 | |
| 2024-06-30 | 98 | US$8.7亿 | 0 | |
| 2024-03-31 | 95 | US$8.1亿 | 0 | |
| 2023-12-31 | 82 | US$5.5亿 | 0 | |
| 2023-09-30 | 81 | US$3.6亿 | 0 | |
| 2023-06-30 | 70 | US$2.9亿 | 0 | |
| 2023-03-31 | 74 | US$3.0亿 | 0 | |
| 2022-12-31 | 63 | US$2.5亿 | 0 | |
| 2022-09-30 | 64 | US$3.6亿 | 0 | |
| 2022-06-30 | 54 | US$2.4亿 | 0 | |
| 2022-03-31 | 59 | US$6.3亿 | 0 | |
| 2021-12-31 | 55 | US$2.8亿 | 0 | |
| 2021-09-30 | 73 | US$4.0亿 | 0 | |
| 2021-06-30 | 69 | US$2.8亿 | 100 | |
| 2021-03-31 | 72 | US$2.9亿 | 95 | |
| 2020-12-31 | 62 | US$1.9亿 | — |
Affinity Asset Advisors, LLC 在 2026-03-31 最显著的持仓异动： 清仓: Ss Spdr S&p Biotech ETF (XBI); 新建仓: Ss Spdr S&p 500 ETF Trust-us (SPY); 清仓: Ishares Biotechnology ETF (IBB); 清仓: Ventyx Biosciences INC (VTYXUSD); 清仓: Amgen INC (AMGN).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ERAS | Erasca INC | +3.6% | +37.18% | 加仓 |
| 2 | 260 | Centessa Pharmaceuticals-adr | +2% | +133.12% | 加仓 |
| 3 | ROIV | Roivant Sciences Ltd. | +1.9% | +64.71% | 加仓 |
| 4 | XENE | Xenon Pharmaceuticals INC | +1.8% | +34.00% | 加仓 |
| 5 | ANAB | Anaptysbio INC | +1.5% | +111.38% | 加仓 |
| 6 | DNTH | Dianthus Therapeutics INC | +1.5% | +247.83% | 加仓 |
| 7 | STRO | Sutro Biopharma INC | +0.9% | +42.91% | 加仓 |
| 8 | ALKS | Alkermes plc | +0.9% | +35.00% | 加仓 |
| 9 | COGT | Cogent Biosciences INC | +0.8% | +114.29% | 加仓 |
| 10 | ASND | Ascendis Pharma A/S | +0.8% | +216.67% | 加仓 |
| 11 | SYRE | Spyre Therapeutics INC | +0.7% | -10.71% | 减仓 |
| 12 | CATX | Perspective Therapeutics INC | +0.6% | +954.86% | 加仓 |
| 13 | OVID | Ovid Therapeutics INC | +0.6% | +48.76% | 加仓 |
| 14 | RVMD | Revolution Medicines INC | +0.6% | +100.00% | 加仓 |
| 15 | MDGL | Madrigal Pharmaceuticals INC | +0.5% | +76.67% | 加仓 |
| 16 | EPRX | Eupraxia Pharmaceuticals INC | +0.5% | +429.67% | 加仓 |
| 17 | ARWR | Arrowhead Pharmaceuticals In | +0.4% | +185.71% | 加仓 |
| 18 | COGT 1.625 11-15-31 | Cogent Biosciences INC | +0.4% | +600.00% | 加仓 |
| 19 | BLTE | Belite Bio INC - Adr | +0.4% | +225.00% | 加仓 |
| 20 | APGE | Apogee Therapeutics INC | +0.3% | +4.05% | 加仓 |
| 21 | 430 | Terns Pharmaceuticals INC | +0.3% | +2.30% | 加仓 |
| 22 | ACLXGBX | Arcellx INC | +0.2% | -30.73% | 减仓 |
| 23 | ✓ | Establishment Labs Hldgs INC | -0.5% | -50.00% | 减仓 |
| 24 | CGEM | Cullinan Therapeutics INC | -0.6% | -59.56% | 减仓 |
| 25 | TSHA | Taysha Gene Therapies INC | -0.8% | -69.70% | 减仓 |
| 26 | BBIO | Bridgebio Pharma INC | -0.8% | -53.13% | 减仓 |
| 27 | QURE | uniQure N.V. | -0.9% | -64.71% | 减仓 |
| 28 | ABVX | Abivax Sa-adr | -1.6% | -19.80% | 减仓 |
| 29 | WVE | Wave Life Sciences Ltd. | -2.1% | -48.08% | 减仓 |
| 30 | XBI | Ss Spdr S&p Biotech ETF | — | EXIT | 清仓 |
| 31 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | 新建仓 |
| 32 | IBB | Ishares Biotechnology ETF | — | EXIT | 清仓 |
| 33 | VTYXUSD | Ventyx Biosciences INC | — | EXIT | 清仓 |
| 34 | AMGN | Amgen INC | — | EXIT | 清仓 |
| 35 | MRNA | Moderna INC | — | NEW | 新建仓 |
| 36 | XLV | Ss Health Care Select Sector | — | EXIT | 清仓 |
| 37 | ELVN | Enliven Therapeutics INC | — | NEW | 新建仓 |
| 38 | BMY | Bristol-myers Squibb Co | — | NEW | 新建仓 |
| 39 | ✓ | Helix Acquisition CORP Iii | — | NEW | 新建仓 |
| 40 | DMRA | Damora Therapeutics INC | — | NEW | 新建仓 |
| 41 | ANRO | Alto Neuroscience INC | — | NEW | 新建仓 |
| 42 | TVTX 2.25 03-01-29 | Travere Therapeutics INC | — | EXIT | 清仓 |
| 43 | TYRA | Tyra Biosciences INC | — | NEW | 新建仓 |
| 44 | IBRX | Immunitybio INC | — | NEW | 新建仓 |
| 45 | TNGX | Tango Therapeutics INC | — | EXIT | 清仓 |
| 46 | KRRO | Korro Bio INC | — | NEW | 新建仓 |
| 47 | RCUS | Arcus Biosciences INC | — | EXIT | 清仓 |
| 48 | CRSP | CRISPR Therapeutics AG | — | NEW | 新建仓 |
| 49 | SGP | Spyglass Pharma INC | — | NEW | 新建仓 |
| 50 | NVO | Novo-nordisk A/s-spons Adr | — | NEW | 新建仓 |
| 季度 | 申报日期 | 类型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-13 | 13F-HR | 在 EDGAR 上查看 |
| 2025-09-30 | 2025-11-13 | 13F-HR | 在 EDGAR 上查看 |
| 2025-06-30 | 2025-08-13 | 13F-HR | 在 EDGAR 上查看 |
| 2025-03-31 | 2025-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-12-31 | 2025-02-13 | 13F-HR | 在 EDGAR 上查看 |
| 2024-09-30 | 2024-11-13 | 13F-HR | 在 EDGAR 上查看 |
| 2024-06-30 | 2024-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-03-31 | 2024-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2023-12-31 | 2024-02-13 | 13F-HR | 在 EDGAR 上查看 |
| 2023-09-30 | 2023-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2023-06-30 | 2023-08-21 | 修正案 | 在 EDGAR 上查看 |
| 2023-06-30 | 2023-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2023-03-31 | 2023-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2022-12-31 | 2023-02-13 | 13F-HR | 在 EDGAR 上查看 |
| 2022-09-30 | 2022-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2022-06-30 | 2022-08-12 | 13F-HR | 在 EDGAR 上查看 |
| 2022-03-31 | 2022-05-13 | 13F-HR | 在 EDGAR 上查看 |
| 2021-12-31 | 2022-02-11 | 13F-HR | 在 EDGAR 上查看 |
| 2021-09-30 | 2021-11-12 | 13F-HR | 在 EDGAR 上查看 |
| 2021-06-30 | 2021-08-13 | 13F-HR | 在 EDGAR 上查看 |
| 2021-03-31 | 2021-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2020-12-31 | 2021-02-12 | 13F-HR | 在 EDGAR 上查看 |
资产规模相近的机构
CIK 0001483532
申报总市值
US$19.4亿
60 stks
2020-09-30
数据过旧，未更新
资产规模与本机构相差仅 0.0%
CIK 0001047142
申报总市值
US$19.4亿
262 stks
2026-06-30
资产规模与本机构相差仅 0.1%
CIK 0001163902
申报总市值
US$19.4亿
395 stks
2026-03-31
资产规模与本机构相差仅 0.1%
持仓风格相似的机构
CIK 0001615982
申报总市值
US$26.8亿
33 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Apogee Therapeutics INC
CIK 0000014745
申报总市值
US$4.0亿
1,021 stks
2026-03-31
前五大持仓重叠 1/5 档，同样重仓 Ss Spdr S&p 500 ETF Trust-us
CIK 0000018349
申报总市值
US$87.4亿
1,549 stks
2025-09-30
数据过旧，未更新
前五大持仓重叠 1/5 档，同样重仓 Ss Spdr S&p 500 ETF Trust-us